ARCHIVES

Funding Opportunities; Program Announcements Released By NCI

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Et2’s Referral Guidelines

July 23, 1993

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

NEW OIG Awards Bring Total to 58

November 13, 1987

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

UICC Announces Grant Programs to Continue

April 15, 1977